Keyphrases
Acute Lung Injury
100%
Anticoagulant Therapy
100%
Operating Instructions
100%
Recombinant Human Activated Protein C
57%
Sepsis
28%
Multicenter Trial
14%
Fibrin Deposition
14%
Ovine
14%
Poor Outcome
14%
Pulmonary Function
14%
Randomized Placebo-controlled Trial
14%
Beneficial Effects
14%
Coagulation Cascade
14%
Histological Analysis
14%
Endotoxin
14%
Severe Sepsis
14%
Placebo Groups
14%
Ventilator-free Days
14%
Critical Care
14%
Anticoagulant Treatment
14%
60-day Mortality
14%
Daily Clinical Practice
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
100%
Anticoagulant Agent
100%
Drotrecogin
57%
Sepsis
42%
Placebo
28%
Syndrome
14%
Bleeding
14%
Endotoxin
14%
Protein C
14%
Neuroscience
Antithrombotic
100%
Drotrecogin Alfa
100%
Anticoagulant
100%
Placebo
50%
Protein C
25%